On Cctober 24, 2017 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported that its third quarter 2017 financial results will be reported on Tuesday, November 7, 2017 (Press release, BioCryst Pharmaceuticalsa, OCT 24, 2017, View Source [SID1234521111]).

BioCryst will host a conference call and webcast at 11:00 a.m. Eastern Time to discuss financial results and to provide an update regarding the Company’s clinical development programs. The call will be led by Jon P. Stonehouse, President & Chief Executive Officer, Thomas R. Staab II, Senior Vice President & Chief Financial Officer, and Dr. Bill Sheridan, Senior Vice President and Chief Medical Officer.

Links to a live audio webcast and replay of the presentation may be accessed on the BioCryst website events page at View Source